Expres2ion Biotech Holding AB
SE0023261292 · FIRST NORTH SWEDEN
1 director and manager of Expres2ion Biotech Holding AB have disclosed 3 transactions under MAR Article 19: 3 buys worth €3k and 0 sells worth €0, which reads as net buying. The most recent disclosed transaction was on 2026-10-09. The largest buy was Bent Frandsen (Chief Executive Officer (CEO)/Managing Directory) for €1k. See live cluster buys or start a free 14-day trial to get alerts when Expres2ion Biotech Holding AB insiders trade.
Insiders
1
Net flow
€3k
Bought
€3k
Sold
€0
Buy Expres2ion Biotech Holding AB
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-09 1w ago | BUY | Bent Frandsen Chief Executive Officer (CEO)/Managing Directory | 10,000 | €0.10 | €957 |
| 2026-10-02 2w ago | BUY | Bent Frandsen Chief Executive Officer (CEO)/Managing Directory | 8,000 | €0.10 | €800 |
| 2026-10-01 2w ago | BUY | Bent Frandsen Chief Executive Officer (CEO)/Managing Directory | 12,000 | €0.10 | €1k |